Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-01-31 08:58 am Unchanged | 13G | INTEGRAL AD SCIENCE HOLDING CORP. IAS | Atlas Venture Fund VIII L.P. | 22,722,771 14.770% | 0 (Unchanged) | View |
| 2022-02-07 3:38 pm Purchase | 13G | INTEGRAL AD SCIENCE HOLDING CORP. IAS | Atlas Venture Fund VIII L.P. | 22,722,771 14.760% | 22,722,771 (New Position) | View |
| 2021-02-02 1:01 pm Unchanged | 13G | TRANSLATE BIO INC TBIO | Atlas Venture Fund VIII L.P. | 3,922,008 3.570% | 0 (Unchanged) | View |
| 2021-02-02 1:00 pm Sale | 13G | BICYCLE THERAPEUTICS PLC BCYC | Atlas Venture Fund VIII L.P. | 612,696 2.880% | -750,000 (-55.04%) | View |
| 2020-02-04 3:14 pm Unchanged | 13G | TRANSLATE BIO INC TBIO | Atlas Venture Fund VIII L.P. | 3,922,008 6.530% | 0 (Unchanged) | View |
| 2020-02-04 3:13 pm Purchase | 13G | BICYCLE THERAPEUTICS PLC BCYC | Atlas Venture Fund VIII L.P. | 1,362,696 7.610% | 1,362,696 (New Position) | View |